Get the Stockscreener App
2.34
15.27%
0.31
After Hours:
2.26
-0.08
-3.42%
Omniab Inc stock is traded at $2.34, with a volume of 1.05M.
It is up +15.27% in the last 24 hours and up +2.18% over the past month.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
See More
Previous Close:
$2.03
Open:
$2.07
24h Volume:
1.05M
Relative Volume:
1.59
Market Cap:
$339.24M
Revenue:
$28.94M
Net Income/Loss:
$-54.29M
P/E Ratio:
-5.0355
EPS:
-0.4647
Net Cash Flow:
$-26.02M
1W Performance:
+0.00%
1M Performance:
+2.18%
6M Performance:
+16.42%
1Y Performance:
+41.82%
1-Day Range:
$2.05
$2.34
1-Week Range:
$2.00
$2.38
52-Week Range:
$1.30
$2.79
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.34 | 339.24M | 28.94M | -54.29M | -26.02M | -0.4647 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com - Investing.com Australia
OmniAb shareholders elect directors and ratify auditor at annual meeting - Investing.com UK
OmniAb Shareholders Approve Directors and Auditor at Meeting - TipRanks
OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants - Stock Titan
OmniAb (OABI) director adds shares through RSU vesting and new equity grants - Stock Titan
OmniAb (OABI) director receives options and RSUs, exercises 20,000 shares - Stock Titan
OmniAb (OABI) director granted stock options and RSUs - Stock Titan
OmniAb (OABI) director adds options and RSUs in Form 4 filing - Stock Titan
OmniAb (OABI) director gains stock, options and RSUs in Form 4 - Stock Titan
OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor - Stock Titan
OmniAb Inc (OABIW) Institutional Confidence - TradingKey
OmniAb Inc (OABIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Is OmniAb Gaining Attention In The Biotechnology Landscape? - Kalkine Media
OmniAb Inc (OABI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Institutional Confidence - TradingKey
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc (OABIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
OmniAb Inc (OABI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OABI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentAnalyst Consensus Shift - newsline.com
OmniAb, Inc. Hits New 52-Week High of $2.79 Amidst Market Challenges - MarketsMojo
Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth - Yahoo Finance
OABI Stock Price, Quote & Chart | OMNIAB INC (NASDAQ:OABI) - ChartMill
OmniAb Inc. (OABI) Edges Lower as Stock Nears Key Support ZoneFibonacci Retracement - newsline.com
OmniAb (OABI) Hovers Near Key Support After Slight DeclineRunaway Gap - The Legal Advocate
OABI Q1 2026 Earnings: EPS Beat Masks Ongoing R&D InvestmentsUpward Estimate Revision - newsline.com
OABI Q1 2026 Earnings: Wider-than-Expected Loss Narrows as EPS Surprises PositivelyEarnings Yield Spread - newsline.com
OmniAb, Inc. Hits New 52-Week High at USD 2.73 - Markets Mojo
OmniAb Stock Is Back Near Its High — Why OABI’s Next Few Days Matter - Bez Kabli
OmniAb Inc. (OABI) Gains 3.92% as Stock Approaches Key Resistance at $2.78Narrow Range Breakout - newsline.com
OmniAb Inc. (OABI) Shares Edge Higher as Key Support HoldsOn Balance Volume - thelegaladvocate.com
OmniAb Inc. (OABI) Rallies 3.9% as Stock Tests Key Resistance LevelsLinear Regression - The Legal Advocate
Is OmniAb Positioned To Be A Long-Term Biotech Winner? - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
OmniAb, Inc. Common Stock OABI ) Stock Price Today & Analysis - Gotrade
OmniAb unveils OmniUltra in vivo platform at TIDES USA event - Traders Union
OmniAb, Inc. (OABI) reports Q1 loss, tops revenue estimates - MSN
We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely - Moomoo
TradingKey - TradingKey
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook - MSN
OmniAb, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OABI) 2026-05-11 - Seeking Alpha
Number of shareholders of OmniAb, Inc. – NASDAQ:OABIW - TradingView
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):